| Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma (NCT05376592) | Wake Forest University Health Sciences | 2022-06-17 |
| Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer (NCT05356039) | Umeå University | 2022-04-19 |
| Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids (NCT04821219) | Mayo Clinic | 2022-01-01 |
| A Proof-of-Concept Study Evaluating LINFU™ (NCT05161013) | Adenocyte, LLC | 2021-10-21 |
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma (NCT04331041) | Washington University School of Medicine | 2021-08-24 |
| A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma (NCT06277206) | Zhejiang University | 2021-08-04 |
| Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma (NCT04998552) | Capital Health System, Inc | 2021-06-22 |
| 18F-FAPI PET Imaging in Pancreatic Adenocarcinoma (NCT05884463) | Zhejiang University | 2021-04-01 |
| Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer (NCT04636788) | Huazhong University of Science and Technology | 2020-11-01 |
| PRECISE: Pancreatic Cancer and Exercise (NCT04305067) | Queen's University, Belfast | 2020-08-01 |
| Establishment of Pancreas Cancer and Cancer-associated Fibroblast Using EUS-guided Biopsy Samples (NCT05571956) | Ajou University School of Medicine | 2020-07-01 |
| Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial) (NCT04435067) | IRCCS San Raffaele | 2020-05-27 |
| Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy (NCT04571294) | Humanitas Hospital, Italy | 2020-05-26 |
| Analysis Of The Anxiety-Depressive Pattern, Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24) (NCT04396093) | Michele Reni | 2020-02-10 |
| The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma. (NCT04045730) | Yale University | 2019-11-15 |
| The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly (NCT04164602) | University of Pecs | 2019-10-09 |
| Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer (NCT03492671) | Loma Linda University | 2019-07-17 |
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer (NCT03977233) | UNC Lineberger Comprehensive Cancer Center | 2019-06-12 |
| Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy (NCT04241367) | National Cancer Center, Korea | 2019-03-28 |
| PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma (NCT04099134) | University of Ulm | 2018-10-10 |
| Pancreatic Cancer Dietary Assessment Study (NCT03616431) | The Christie NHS Foundation Trust | 2018-07-03 |
| The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC) (NCT03472716) | Centre Leon Berard | 2018-05-22 |
| Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) (NCT03377491) | NovoCure Ltd. | 2018-05-10 |
| Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues (NCT03544255) | Ying Lv | 2018-05-01 |
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma (NCT03822936) | CNAO National Center of Oncological Hadrontherapy | 2018-02-08 |
| A Study of ASN007 in Patients With Advanced Solid Tumors (NCT03415126) | Asana BioSciences | 2018-01-19 |
| A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer (NCT03331562) | Translational Genomics Research Institute | 2017-12-27 |
| Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study) (NCT03532347) | Newcastle-upon-Tyne Hospitals NHS Trust | 2017-05-22 |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) (NCT02707328) | The Cooper Health System | 2015-01-01 |
| Improving Pancreatic Cancer Care by the Use of Computational Science and Technology (NCT06055010) | UMC Utrecht | 2014-01-01 |
| A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer (NCT02707315) | The Cooper Health System | 2013-01-01 |
| Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma (NCT01413087) | Anchiano Therapeutics Israel Ltd. | 2011-09-01 |
| EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration (NCT01774162) | University of Alberta | 2011-09-01 |
| A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma. (NCT04147403) | Shanghai Jiao Tong University School of Medicine | 2008-01-01 |